Overview
Christian Hyde, MD, is a UW Health radiation oncologist and an assistant professor in the Department of Radiation Medicine at the University of Wisconsin School of Medicine Public Health. He cares for people with cancer using advanced, noninvasive treatments and is committed to helping each person understand their care options in a clear and supportive way.Dr. Hyde specializes in radiation oncology, which uses focused radiation to treat cancer while protecting healthy tissue. His clinical interests include prostate cancer, bladder cancer and cancers of the gastrointestinal system, which include the stomach and intestines. He values the precision of modern radiation therapy and how it can shrink tumors, relieve symptoms and in many cases help cure disease. Dr. Hyde enjoys working with patients from all walks of life and learning what matters most to them as individuals.Dr. Hyde believes the best care comes from strong communication and teamwork. He takes time to listen closely to patients and caregivers and encourages shared decision making so care plans match each patient’s goals and priorities. Having seen loved ones go through cancer treatment himself, he approaches care with empathy, honesty and respect. His goal is to reduce suffering, protect quality of life, and help patients know what to expect at each step of treatment.Outside of work, Dr. Hyde enjoys staying active and spending time outdoors. He loves cycling and hiking and looks forward to exploring local trails. These activities help him recharge and stay connected to the healthy lifestyle he encourages for his patients.
Dr. Hyde is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Thymic Epithelial Tumor, Familial Prostate Cancer, Prostate Cancer, and Pleuropulmonary Blastoma.
Dr. Hyde is board certified in Radiation Oncology. He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 3 clinical trials.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MEDICARE MAPD
- MEDICARE SNP
Locations
600 Highland Ave, Madison, WI 53792
4621 Eastpark Blvd, Madison, WI 53718
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Rogel Cancer Center
Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma.
Henry Ford Cancer-Detroit
Shirish Gadgeel is an Oncologist practicing medicine in Detroit, Michigan. Dr. Gadgeel is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy.
Rogel Cancer Center
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Thyroid Cancer, Throat Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.
Frequently Asked Questions about Dr. Christian Hyde
How do I make an appointment with Dr. Christian Hyde?
You can book an appointment with Dr. Christian Hyde by calling their office at 608-915-1200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Christian Hyde a top-rated expert for Thymic Epithelial Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christian Hyde is classified as an Advanced expert for Thymic Epithelial Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Christian Hyde specialize in?
While Dr. Christian Hyde is a Radiation Oncology, they have specific expertise in Thymic Epithelial Tumor, Familial Prostate Cancer, and Prostate Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Christian Hyde participate in research or clinical trials?
Yes. Dr. Christian Hyde has published 2 articles and abstracts on conditions like Thymic Epithelial Tumor. You can view a list of Dr. Christian Hyde's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Christian Hyde accept my insurance?
Dr. Christian Hyde accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 608-915-1200 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial Prostate CancerDr. Hyde isAdvanced. Learn about Familial Prostate Cancer.
- Lung CancerDr. Hyde isAdvanced. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Hyde isAdvanced. Learn about Pleuropulmonary Blastoma.
- Prostate CancerDr. Hyde isAdvanced. Learn about Prostate Cancer.
- Thymic Epithelial TumorDr. Hyde isAdvanced. Learn about Thymic Epithelial Tumor.
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Hyde isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Hyde isExperienced. Learn about Angiosarcoma.
- AstrocytomaDr. Hyde isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Bone TumorDr. Hyde isExperienced. Learn about Bone Tumor.